RxDoctor Payments Data

Brandi Warren, DO

Family Medicine · Thomasville, GANPI 1417046517

Payments from drug & device makers

$2,817in general payments, 2019–2025

Across 155 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$543
  • Novo Nordisk$336
  • Pfizer$299
  • Merz North America, Inc.$260
  • Lilly USA, LLC$169
  • Astellas Pharma US Inc$149
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$2,817100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,817 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$111,236
Medicare patients
262
Services billed
2,892

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide59$78,069
OzempicSemaglutide68$68,154
EliquisApixaban92$61,317
TrulicityDulaglutide46$46,715
JardianceEmpagliflozin28$26,206
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$20,963
LinzessLinaclotide35$20,622
Tresiba Flextouch U-100Insulin Degludec26$13,419
XareltoRivaroxaban20$10,759
ShingrixVaricella-Zoster Ge/As01b/Pf30$6,569
SynthroidLevothyroxine Sodium45$3,304
Levothyroxine Sodium298$2,933
SymbicortBudesonide/Formoterol Fumarate13$2,908
Duloxetine Hcl117$2,588
Venlafaxine Hcl ErVenlafaxine Hcl47$2,168

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$169$124,784105 claims
Novo NordiskOzempic$336$68,15468 claims
PfizerEliquis$299$61,31792 claims
GSKTrelegy Ellipta, Shingrix$64$27,53257 claims
AbbVieLinzess, Synthroid$543$23,92680 claims
AstraZenecaSymbicort$36$2,90813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Thomasville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →